全文获取类型
收费全文 | 3209572篇 |
免费 | 245762篇 |
国内免费 | 8144篇 |
专业分类
耳鼻咽喉 | 43685篇 |
儿科学 | 104409篇 |
妇产科学 | 87180篇 |
基础医学 | 461856篇 |
口腔科学 | 89416篇 |
临床医学 | 292298篇 |
内科学 | 628670篇 |
皮肤病学 | 73380篇 |
神经病学 | 257399篇 |
特种医学 | 124040篇 |
外国民族医学 | 743篇 |
外科学 | 488177篇 |
综合类 | 70539篇 |
现状与发展 | 14篇 |
一般理论 | 1167篇 |
预防医学 | 256740篇 |
眼科学 | 73367篇 |
药学 | 235277篇 |
13篇 | |
中国医学 | 5970篇 |
肿瘤学 | 169138篇 |
出版年
2018年 | 35042篇 |
2017年 | 26735篇 |
2016年 | 30739篇 |
2015年 | 34571篇 |
2014年 | 48666篇 |
2013年 | 73521篇 |
2012年 | 97244篇 |
2011年 | 103931篇 |
2010年 | 62875篇 |
2009年 | 60044篇 |
2008年 | 97272篇 |
2007年 | 103790篇 |
2006年 | 105157篇 |
2005年 | 102002篇 |
2004年 | 97326篇 |
2003年 | 94185篇 |
2002年 | 90875篇 |
2001年 | 146410篇 |
2000年 | 150262篇 |
1999年 | 126689篇 |
1998年 | 38030篇 |
1997年 | 33515篇 |
1996年 | 34243篇 |
1995年 | 33248篇 |
1994年 | 30741篇 |
1993年 | 28932篇 |
1992年 | 100962篇 |
1991年 | 98526篇 |
1990年 | 95841篇 |
1989年 | 92026篇 |
1988年 | 84923篇 |
1987年 | 83379篇 |
1986年 | 78504篇 |
1985年 | 75497篇 |
1984年 | 56886篇 |
1983年 | 48321篇 |
1982年 | 29341篇 |
1981年 | 26424篇 |
1979年 | 52195篇 |
1978年 | 37564篇 |
1977年 | 31354篇 |
1976年 | 29695篇 |
1975年 | 31623篇 |
1974年 | 37747篇 |
1973年 | 35908篇 |
1972年 | 33766篇 |
1971年 | 31649篇 |
1970年 | 29010篇 |
1969年 | 27625篇 |
1968年 | 25454篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
941.
942.
Costas D Lallas Erik P Castle Richard T Schlinkert Paul E Andrews 《JSLS, Journal of the Society of Laparoendoscopic Surgeons》2006,10(2):135-140
BACKGROUND AND OBJECTIVES: In 1999, our institution began a kidney transplant program with collaboration between the departments of General Surgery/Transplantation and Urology. From the onset, donor nephrectomies were performed laparoscopically and are currently the domain of Urology, which had no prior laparoscopic experience before this undertaking. We reviewed our experience. METHODS: A database of our experience was kept prospectively from June 1999 to November 2004. Records of both donors and recipients were reviewed. Special attention was directed toward our changes in technique and their relationship to outcomes, with emphasis on graft extraction and overall complication rates. RESULTS: We reviewed the records of 205 consecutive procedures. We report excellent donor outcomes, including mean operative time (112 minutes), estimated blood loss (120 mL), and length of stay (2.3 days). Complication (14.1%) and open conversion (1.5%) rates were low. For the recipients, early (98.0%) and 1-year (94.7%) graft survival, and ureteral ischemia (2.4%) rates were also appropriate with contemporary experience. CONCLUSIONS: We report our results on laparoscopic donor nephrectomy in a de novo renal transplant program. Because of this experience, we have ventured into other horizons of urologic laparoscopy and currently produce enough volume to support a laparoscopic fellowship. We feel that a productive donor nephrectomy program can enhance urologic laparoscopic programs and should be taken advantage of when available. 相似文献
943.
BACKGROUND: Posterior spinal procedures through tubular exposures have been described. However, tubes restrain visibility and require co-axial instrument manipulation, increasing difficulty and potentially compromising surgical results. An independent-blade retractor system overcomes the obstacles of working through a tube and has been used to perform minimally-disruptive decompression and instrumented tranforaminal lumbar interbody fusion (TLIF). PURPOSE: To evaluate the advantages to patient recovery and surgical efficacy of this technique. METHODS/RESULTS: Retrospective review of technique employing a minimally-disruptive approach to decompression and transforaminal lumber interbody fusion (TLIF). CONCLUSIONS: Minimally-disruptive decompression and instrumented TLIF can be performed in a safe and effective manner using an independent-blade retractor system. Relative to traditional-open techniques, surgical goals can be accomplished, but with the benefits of minimally-disruptive surgery. 相似文献
944.
945.
INTRODUCTION: The optimal hyperbaric oxygen (HBO2) treatment protocol for acute carbon monoxide (CO) poisoning is unknown. This is indicated by one study that found 18 different protocols to treat CO poisoning by North American multiplace hyperbaric facilities. A pilot study was conducted to evaluate the feasibility of randomizing patients to different protocols and to determine whether any large differences in clinical outcome were present between the two most common protocols. METHODS: Adult patients with accidental CO poisoning resulting in transient loss of consciousness, presentation to the emergency department within 12 hours, primary language English, high school education, and residence within 100 miles of the hyperbaric facility were recruited. Enrolled patients were randomized to one HBO2 treatment at 2.4 atmospheres absolute (atm abs) pressure with 90 minutes of 100% oxygen breathing vs. treatment by the US Air Force CO protocol (3.0 atm abs maximum pressure). A neurocognitive screening test was performed immediately after hyperbaric treatment and repeated 14-21 days later. RESULTS: From 1995 to 2002, 30 patients age 21 to 88 years were randomized, 18 to treatment at 2.4 atm abs and 12 to 3.0 atm abs. Average carboxyhemoglobin level for the population was 24.8 +/- 8.8% (mean +/- SD). Delay to hyperbaric treatment averaged 313 +/- 129 minutes. Neither variable was different between treatment groups. Six patients had abnormal neurocognitive testing immediately following hyperbaric treatment, 4 in the 2.4 atm abs group (22%) and 2 in the 3.0 atm abs group (17%) (P=0.71). One patient in each group demonstrated abnormality on delayed testing (p=0.75). One in each group did not return for follow-up. CONCLUSIONS: It is feasible to randomize CO-poisoned patients to different hyperbaric treatment protocols. Determination of differences in efficacy between treatment protocols will require a large multicenter trial with the use of detailed neurocognitive testing. 相似文献
946.
Hazel B Breitz Richard E Wendt Michael S Stabin Sui Shen William D Erwin Joseph G Rajendran Janet F Eary Lawrence Durack Ebrahim Delpassand William Martin Ruby F Meredith 《Journal of nuclear medicine》2006,47(3):534-542
166Ho-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetramethylene-phosphonate (DOTMP) is a tetraphosphonate molecule radiolabeled with 166Ho that localizes to bone surfaces. This study evaluated pharmacokinetics and radiation-absorbed dose to all organs from this beta-emitting radiopharmaceutical. METHODS: After two 1.1-GBq administrations of 166Ho-DOTMP, data from whole-body counting using a gamma-camera or uptake probe were assessed for reproducibility of whole-body retention in 12 patients with multiple myeloma. The radiation-absorbed dose to normal organs was estimated using MIRD methodology, applying residence times and S values for 166Ho. Marrow dose was estimated from measured activity retained after 18 h. The activity to deliver a therapeutic dose of 25 Gy to the marrow was determined. Methods based on region-of-interest (ROI) and whole-body clearance were evaluated to estimate kidney activity, because the radiotracer is rapidly excreted in the urine. The dose to the surface of the bladder wall was estimated using a dynamic bladder model. RESULTS: In clinical practice, gamma-camera methods were more reliable than uptake probe-based methods for whole-body counting. The intrapatient variability of dose calculations was less than 10% between the 2 tracer studies. Skeletal uptake of 166Ho-DOTMP varied from 19% to 39% (mean, 28%). The activity of 166Ho prescribed for therapy ranged from 38 to 67 GBq (1,030-1,810 mCi). After high-dose therapy, the estimates of absorbed dose to the kidney varied from 1.6 to 4 Gy using the whole-body clearance-based method and from 8.3 to 17.3 Gy using the ROI-based method. Bladder dose ranged from 10 to 20 Gy, bone surface dose ranged from 39 to 57 Gy, and doses to other organs were less than 2 Gy for all patients. Repetitive administration had no impact on tracer biodistribution, pharmacokinetics, or organ dose. CONCLUSION: Pharmacokinetics analysis validated gamma-camera whole-body counting of 166Ho as an appropriate approach to assess clearance and to estimate radiation-absorbed dose to normal organs except the kidneys. Quantitative gamma-camera imaging is difficult and requires scatter subtraction because of the multiple energy emissions of 166Ho. Kidney dose estimates were approximately 5-fold higher when the ROI-based method was used rather than the clearance-based model, and neither appeared reliable. In future clinical trials with 166Ho-DOTMP, we recommend that dose estimation based on the methods described here be used for all organs except the kidneys. Assumptions for the kidney dose require further evaluation. 相似文献
947.
E. G. Paronikyan A. S. Noravyan Sh. F. Akopyan F. G. Arsenyan G. M. Stepanyan B. T. Garibdzhanyan 《Pharmaceutical Chemistry Journal》2006,40(6):293-295
Methods for the synthesis of new heterosystems of condensed thieno[3,2-d]-1,2,3-triazines on the basis of pyrido[2,3-b]thiophenes
have been developed. The antitumor activity of the synthesized compounds was studied and several compounds possessing low
toxicity and moderate antitumor activity were found.
__________
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 40, No. 6, pp. 3–5, June, 2006. 相似文献
948.
949.
Vacuum-assisted closure (VAC), although a modern adjunct in wound management, has not been used previously in pyoderma gangrenosum (PG), probably to avoid the potential complications of ‘pathergy’. We would like to report our experience of VAC in three cases of PG with the relevant review of literature. 相似文献
950.